You have 9 free searches left this month | for more free features.

rituximab versus azathioprine

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Eosinophilic Granulomatosis With Polyangiitis Trial in Paris (Rituximab, Azathioprine, Placebo-rituximab)

Recruiting
  • Eosinophilic Granulomatosis With Polyangiitis
  • Paris, France
    Hôpital Cochin
Feb 9, 2022

Acute Demyelinating Syndrome Trial in France (Immediate Azathioprine (1st attack), Immediate Rituximab (1st attack), Standard of

Not yet recruiting
  • Acute Demyelinating Syndrome
  • Immediate Azathioprine (1st attack)
  • +2 more
  • Besançon, France
  • +8 more
Sep 14, 2022

Immune Thrombocytopenia Purpura Trial in Cairo (Dexamethasone, Prednisolone and Azathioprine, Rituximab)

Recruiting
  • Immune Thrombocytopenia Purpura
  • Cairo, Egypt
    EL-Kasr elineiy
May 6, 2023

Atopic Dermatitis Trial in Sari (Baricitinib 4 MG, Azathioprine 1.5-2.5 mg/kg)

Not yet recruiting
  • Atopic Dermatitis
  • Baricitinib 4 MG
  • Azathioprine 1.5-2.5 mg/kg
  • Sari, Mazandaran, Iran, Islamic Republic of
    Iran
Aug 1, 2023

Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • Atlanta, Georgia
    Northside Hospital
Sep 21, 2023

Crohn Disease Trial (Azathioprine + infliximab, Intestinal resection)

Not yet recruiting
  • Crohn Disease
  • Azathioprine + infliximab
  • Intestinal resection
  • (no location specified)
Oct 14, 2022

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Nephrotic Syndrome in Children Trial in Chongqing (Rituximab, Mycophenolate Mofetil)

Recruiting
  • Nephrotic Syndrome in Children
  • Chongqing, Chongqing, China
    Children's Hospital of Chongqing Medical University
May 3, 2023

Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)

Not yet recruiting
  • Primary Ocular Adnexal MALT Lymphoma
  • (no location specified)
Sep 26, 2023

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Wegener Granulomatosis Trial in Worldwide

Completed
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  • +2 more
  • Los Angeles, California
  • +37 more
Feb 18, 2022

Splenic Marginal Zone Lymphoma Trial in Worldwide (Rituximab, Zanubrutinib)

Not yet recruiting
  • Splenic Marginal Zone Lymphoma
  • Aarhus, Denmark
  • +4 more
Feb 17, 2023

Pharmacological Action Trial (Rituximab, Dexamethasone)

Not yet recruiting
  • Pharmacological Action
  • (no location specified)
Sep 22, 2022

Steroid-Dependent Nephrotic Syndrome, Steroid-Sensitive Nephrotic Syndrome Trial in Paris (single infusion of Rituximab, single

Not yet recruiting
  • Steroid-Dependent Nephrotic Syndrome
  • Steroid-Sensitive Nephrotic Syndrome
  • single infusion of Rituximab
  • single infusion of Obinutuzumab
  • Paris, France
    Robert Debre Hospital
Mar 14, 2023

Renal Transplant Trial in Seoul (Rituximab, intravenous immune globulin)

Completed
  • Renal Transplant
  • Seoul, Korea, Republic of
  • +1 more
Oct 25, 2022

Large B-Cell Lymphoma Trial in Xi'an (Glofitamab, Polatuzumab vedotin, Rituximab)

Not yet recruiting
  • Large B-Cell Lymphoma
  • Xi'an, China
    First Affiliated Hospital of Medical College of Xi'an Jiaotong U
Sep 14, 2023

Lymphocytic Myocarditis (Disorder), Heart Failure, Dilated Cardiomyopathy Trial in Moscow (mycophenolate mofetil 2 g per day,

Recruiting
  • Lymphocytic Myocarditis (Disorder)
  • +4 more
  • mycophenolate mofetil 2 g per day
  • azathioprine of 150 [75; 150] mg per day
  • Moscow, Bol'shaya Pirogovskaya Street 6, 1 Building ,, Russian Federation
    I.M. Sechenov First Moscow State Medical University (Sechenov Un
Feb 2, 2022

Nephrotic Syndrome Steroid-Dependent Trial in Genova (Rituximab Biosimilar)

Recruiting
  • Nephrotic Syndrome Steroid-Dependent
  • Rituximab Biosimilar
  • Genova, Italy
    IRCCS G. Gaslini
Dec 19, 2022

Relapsed/Refractory Marginal Zone Lymphoma Trial in China (Orelabrutinib, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Marginal Zone Lymphoma
  • Guangzhou, Guangdong, China
  • +10 more
Oct 8, 2023

Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

Not yet recruiting
  • Mantle Cell Lymphoma
  • (no location specified)
Nov 22, 2022

Relapsed/Refractory Marginal Zone Lymphoma Trial in Westbury (Zanubrutinib, Rituximab, Lenalidomide)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Westbury, New York
    Clinical Research Alliance, Inc.
Nov 14, 2022

Interstitial Lung Disease, Scleroderma, Idiopathic Inflammatory Myositis Trial in London (Rituximab, Cyclophosphamide)

Completed
  • Interstitial Lung Disease
  • +3 more
  • London, United Kingdom
    Royal Brompton Hospital
Oct 6, 2021

Interstitial Lung Disease, Scleroderma Trial in Assiut (Rituximab, IL6 inhibitor)

Completed
  • Interstitial Lung Disease
  • Scleroderma
  • Assiut, Yes, Egypt
    Manal Hassanien
Jul 18, 2023

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

Therapeutic Equivalency Trial in Leicester, Manchester (Azathioprine 50Mg Tab, Azathioprine 10mg/mL oral suspension)

Completed
  • Therapeutic Equivalency
  • Azathioprine 50Mg Tab
  • Azathioprine 10mg/mL oral suspension
  • Leicester, Leicestershire, United Kingdom
  • +1 more
Jun 21, 2021